The European Union (EU) is to advance a grant of 32 million euros for Ghana to support the development of vaccine manufacturing and the pharmaceutical industry in the country.
Under the EU initiative on the Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+) which was initiated in 2021, part of the grant would be used to finance the construction of a vaccine manufacturing plant in Ghana.
An agreement for the release of the grant was signed between Ghana and EU in Accra as part of the…